Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

2013 ASCO Annual Meeting

May 15th, 2013

Genentech to report new advances at the American Society of Clinical Oncology Annual Meeting

Genentech will present important new data from studies of several cancer medicines at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) from May 31-June 4, 2013, in Chicago.

This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.


About the Lung Cancer Project


Data from The Lung Cancer Project, a study exploring if people, including doctors, have inherent biases against lung cancer, is being presented at this year’s meeting.
Learn more


Fact Sheets

ASCO Digital Newsroom

Visit our ASCO newsroom to read more about this year's key topics at ASCO.


By The Numbers

275
Abstracts at ASCO
96
Oral Presentations at the meeting
10
Pipeline Medicines with Data